ELEA S A C I F Y A LAB has a total of 19 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Argentina, Mexico and Peru. Its main competitors in its focus markets organic fine chemistry, biotechnology and pharmaceuticals are MICROLOGIX BIOTECH INC, KORIKSA CORP and BOSTON LIFE SCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Argentina | 9 | |
#2 | Mexico | 2 | |
#3 | Peru | 2 | |
#4 | Brazil | 1 | |
#5 | Chile | 1 | |
#6 | Colombia | 1 | |
#7 | Dominican Republic | 1 | |
#8 | United States | 1 | |
#9 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Biotechnology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Sugars | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Sterpetti Cecilia | 7 |
#2 | Campa Fernando Rodolfo | 6 |
#3 | Tizado Andrea Gabriela | 4 |
#4 | Cassani Norberto | 2 |
#5 | Ermacora Mario Roberto | 2 |
#6 | Primo Maria Evangelina | 2 |
#7 | Sica Mauricio Pablo | 2 |
#8 | Poskus Edgardo | 2 |
#9 | Andrea Fabriela Tizado Cecilia | 1 |
#10 | Larrosa Pomi Jose Daniel | 1 |
Publication | Filing date | Title |
---|---|---|
MX2007014056A | Solid pharmaceutical composition for the oral administration of ibandronaic acid or salts or a pharmaceutically acceptable hydrate thereof, process for the preparation of said composition by direct compression, pharmaceutical formulations containing | |
US7339040B2 | DNA molecules optimized sequences that encode the IA-2IC antigen, RNA molecules, expression vectors, transformed cells, method of preparing the IA-2IC antigen, polypeptide of the human IA-2IC antigen, and in vitro procedure and kit for the diagnosis of autoimmune diabetes | |
MXPA02006065A | A pediculicidal composition. |